Pediatrics

1092 questions

Question 361Question →

A mother brings her male infant to the office for a health supervision visit. The child is chronologically 15 months old. He was delivered at 28 weeks gestation due to severe maternal preeclampsia. He spent 8 weeks in the neonatal intensive care unit but was discharged without major complications. His immunizations were current up until his 6-month visit. Due to a temporary out-of-state relocation, he missed his subsequent well-child checks. At 11 months of chronological age, he was hospitalized for 6 days with prolonged high fever, bilateral nonexudative conjunctivitis, oral mucosal changes, and cervical lymphadenopathy. He received treatment with high-dose intravenous immunoglobulin (IVIG) and high-dose aspirin, which led to rapid clinical improvement. He currently takes no medications.

During today's visit, the mother expresses deep concern because the child is not yet walking without support, whereas his older sister walked at 11 months. The patient is able to pull himself to a standing position and walk along the couch. He accurately picks up small cereal pieces using his thumb and index finger. He points to his toys when he wants them and calls his parents 'mama' and 'dada' appropriately. Vital signs and physical examination are unremarkable.

Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Reassure the mother regarding his development and administer the DTaP, Hib, PCV, and hepatitis A vaccines

Answer

Reassure the mother regarding his development and administer the DTaP, Hib, PCV, and hepatitis A vaccines
The correct management combines reassuring the mother because the infant's development is appropriate for his corrected age, and administering only inactivated vaccines because live vaccines are temporarily contraindicated following high-dose intravenous immunoglobulin (IVIG) therapy. For infants born prematurely, chronological age should be corrected for the degree of prematurity when assessing developmental milestones until 24 months of age. This child was born at 28 weeks gestation (12 weeks or 3 months premature). At a chronological age of 15 months, his corrected age is 12 months. His milestones—cruising, fine pincer grasp, specific 'mama/dada', and pointing—are perfectly aligned with a 12-month developmental level. Therefore, reassurance rather than early intervention is appropriate. Furthermore, he is due for several vaccines since he missed his visits after 6 months. High-dose IVIG, standard therapy for Kawasaki disease (which he had at 11 months), contains antibodies that interfere with the replication of live-attenuated viral vaccines. Consequently, measles, mumps, and rubella (MMR) and varicella vaccines must be deferred for 11 months after high-dose IVIG administration. Inactivated vaccines (DTaP, Hib, PCV, hepatitis A) are not affected by circulating passive antibodies and should be administered today.

Step-by-Step Solution

1
Calculate the patient's corrected age to accurately assess developmental milestones.
The infant is 15 months chronological age, but was born at 28 weeks gestation (12 weeks, or 3 months, premature). Therefore, his corrected age is 12 months.
Premature infants must have their chronological age adjusted for the degree of prematurity until they reach 24 months of age to avoid false diagnoses of developmental delay.
2
Compare the patient's current abilities to expected milestones for a 12-month-old.
Cruising (walking along furniture), neat pincer grasp, specific 'mama/dada', and pointing are all normal and expected milestones for a 12-month-old. No developmental delay is present.
Proper assessment determines whether parental reassurance or an early intervention referral is medically indicated.
3
Identify the implications of the patient's recent treatment for Kawasaki disease on his immunization schedule.
The patient received high-dose IVIG at 11 months of age. Live-attenuated vaccines must be deferred for 11 months post-infusion.
Passive antibodies present in IVIG will neutralize live vaccine viruses (e.g., MMR, varicella) before they can elicit an immune response, rendering them ineffective.
4
Determine which of the indicated catch-up vaccines are live versus inactivated.
MMR and varicella are live vaccines and must be deferred. DTaP, Hib, PCV, and hepatitis A are inactivated vaccines and can be administered safely today.
Inactivated vaccines are not affected by circulating passive antibodies from IVIG and are necessary to bring the patient up to date on his immunization schedule.

Key Concept

Assessment of developmental milestones using corrected age for prematurity, and the contraindication of live-attenuated vaccines following high-dose intravenous immunoglobulin (IVIG) therapy.
Estimated Time:1m 30s
Question 362Question →

A term neonate born at 39 weeks gestation is diagnosed with alloimmune hemolytic disease secondary to ABO incompatibility. The infant's unconjugated total serum bilirubin levels are monitored closely. Management of neonatal hyperbilirubinemia follows a specific escalation protocol based on neurotoxicity risk factors and bilirubin levels to prevent kernicterus. Arrange the following therapeutic interventions in the correct standard sequence of clinical escalation, starting from the most basic baseline management to the most invasive rescue therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The standard sequence of escalation is: Optimize enteral feeding and ensure adequate hydration, followed by Initiation of intensive phototherapy, then Administration of intravenous immunoglobulin (IVIG), and finally Performing a double-volume exchange transfusion.
The treatment of neonatal hyperbilirubinemia follows a stepwise escalation based on bilirubin neurotoxicity risk. Baseline management involves maximizing enteral feeding to ensure adequate stooling, which interrupts the enterohepatic circulation of bilirubin. If bilirubin rises to the phototherapy threshold on the risk-stratified nomogram, intensive phototherapy is initiated to convert unconjugated bilirubin into excretable, water-soluble isomers. In cases of isoimmune hemolytic disease (such as ABO or Rh incompatibility) where bilirubin continues to rise rapidly toward exchange transfusion levels despite intensive phototherapy, IVIG is administered to block red blood cell destruction. Finally, if the bilirubin level reaches critical thresholds or the infant demonstrates signs of acute bilirubin encephalopathy, double-volume exchange transfusion is emergently performed as a definitive rescue measure.

Step-by-Step Solution

1
Identify the foundational requirement for all jaundiced neonates.
Optimize enteral feeding and ensure adequate hydration is the first step.
Enteral feeding promotes stooling, which is the primary route of bilirubin excretion, thereby minimizing enterohepatic recirculation.
2
Determine the first-line active medical intervention when bilirubin crosses the treatment threshold.
Initiate intensive phototherapy is the second step.
Phototherapy is a safe, non-invasive method that structurally isomerizes unconjugated bilirubin into water-soluble forms that can be excreted in urine and bile.
3
Select the next pharmacological step for isoimmune hemolytic disease refractory to initial therapy.
Administer intravenous immunoglobulin (IVIG) is the third step.
IVIG is specifically indicated in alloimmune hemolytic disease when bilirubin approaches exchange levels despite phototherapy; it reduces hemolysis by blocking Fc receptors.
4
Identify the ultimate rescue therapy for critically severe hyperbilirubinemia.
Perform a double-volume exchange transfusion is the final step.
This highly invasive procedure is reserved as a last resort to rapidly decrease total bilirubin and remove maternal antibodies when all other measures fail or if neurological symptoms appear.

Key Concept

Escalation protocol for neonatal alloimmune hyperbilirubinemia
Question 363Question →

A 12-month-old boy is brought to the clinic for a routine well-child visit. Three months ago, he was hospitalized for prolonged fever, bilateral nonexudative conjunctivitis, oral mucosal changes, and a polymorphous rash. He was diagnosed with Kawasaki disease and successfully treated with a single dose of intravenous immunoglobulin (IVIG) and high-dose aspirin. He is currently asymptomatic, his recent echocardiograms have been normal, and he takes low-dose aspirin daily. Physical examination today reveals a healthy, active infant. His growth parameters are at the 50th percentile. He received all recommended immunizations up to his 6-month visit. According to current guidelines, which of the following is the most appropriate immunization plan for this patient today?

Show answer & explanation

Answer: Administer pneumococcal conjugate, Haemophilus influenzae type b, and hepatitis A vaccines; defer MMR and varicella vaccines.

Answer

The correct plan is to administer inactivated vaccines (pneumococcal conjugate, Haemophilus influenzae type b, and hepatitis A) and defer live-attenuated vaccines (MMR and varicella).
The correct plan administers inactivated vaccines and defers live vaccines. A 12-month-old infant is normally due for both inactivated vaccines (PCV, Hib, HepA) and live-attenuated vaccines (MMR, Varicella). However, this patient received high-dose intravenous immunoglobulin (IVIG) 3 months ago for Kawasaki disease. IVIG contains a concentrated pool of exogenous IgG antibodies that will bind to and neutralize live-attenuated viral vaccines, rendering them ineffective. Therefore, live vaccines must be deferred (an 11-month delay is required following the high doses of IVIG used for Kawasaki disease). Because inactivated vaccines do not require viral replication to induce an immune response, they are completely unaffected by circulating exogenous antibodies and must be administered on their normal schedule to ensure continuous protection.

Step-by-Step Solution

1
Identify the standard vaccines indicated at a 12-month well-child visit.
The standard schedule includes both inactivated vaccines (PCV, Hib, HepA) and live-attenuated vaccines (MMR, Varicella).
Establishing the baseline vaccine requirements is the first step in well-child care.
2
Evaluate the impact of the patient's past medical history on the vaccination schedule.
The patient received high-dose IVIG for Kawasaki disease 3 months ago.
Medical treatments, particularly blood products, can alter immunization protocols.
3
Apply the rules for vaccine administration following IVIG therapy.
Live-attenuated vaccines must be deferred for 11 months post-IVIG, while inactivated vaccines can be given safely on schedule.
Exogenous antibodies in IVIG neutralize live vaccine viruses but do not affect the immune response to inactivated antigens.

Key Concept

Administration of antibody-containing products like IVIG necessitates a delay in giving live-attenuated viral vaccines (e.g., MMR, Varicella) because passive antibodies interfere with the active immune response. Inactivated vaccines are not affected and should be given on schedule.
Question 364Question →

A 15-month-old boy is brought to the office by his parents for a routine well-child visit. His parents are anxious because they noticed other children his age at daycare are running and putting words together. They report that their son currently walks well independently but frequently falls when he tries to move more quickly. He says "mama," "dada," "baba," and "up." He consistently points to objects he wants and brings books to his parents to read. He can drink from a cup, scribble on paper with a crayon, and build a tower of two blocks. He responds to his name and easily follows simple commands, such as "bring me the ball," when his mother points to the object. His physical examination, including muscle tone and deep tendon reflexes, is within normal limits. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Continue with age-appropriate health maintenance

Answer

Continue with age-appropriate health maintenance
The correct answer is to continue with age-appropriate health maintenance. This patient is meeting all typical milestones for a 15-month-old child. At 15 months, a child is expected to walk independently, have a vocabulary of 3 to 5 words, point to objects of interest (joint attention), follow 1-step commands with gestures, and demonstrate fine motor skills like scribbling and building a tower of 2 blocks. The parents' concerns regarding the child's inability to run or combine words are premature; running is typically mastered around 18 months, and combining words into simple two-word phrases is expected at 24 months. Because the child's development is entirely on track, reassurance and routine follow-up are the most appropriate steps.

Step-by-Step Solution

1
Evaluate the patient's gross motor and fine motor milestones.
The patient walks independently, drinks from a cup, scribbles, and builds a 2-block tower.
These perfectly align with the expected milestones for a 15-month-old child.
2
Evaluate the patient's speech, language, and social milestones.
The patient has a 4-word vocabulary, points to objects, and follows 1-step commands with a gesture.
These align with expected 15-month milestones. Two-word phrases are not expected until 24 months.
3
Determine the next best step based on the milestone analysis.
Since all milestones are age-appropriate, no specialty referrals or early diagnostic testing are indicated.
Misinterpreting normal developmental progression as delayed leads to unnecessary and costly interventions.

Key Concept

Normal pediatric developmental milestones at 15 months of age include independent walking, a 3-5 word vocabulary, following a 1-step command with a gesture, and pointing to objects of interest.
Question 365Question →

A pediatric care team is counseling the parents of a healthy term newborn regarding the expected timeline of standard well-child visits, vaccinations, and developmental screenings. The parents wish to strictly adhere to the standard Bright Futures guidelines and the Centers for Disease Control and Prevention (CDC) recommended immunization schedule. Arrange the following preventive care interventions in the chronological order in which they are routinely first recommended to be administered or performed, from earliest in the child's life to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Hepatitis B vaccine (Birth), Rotavirus vaccine (2 months), Inactivated influenza vaccine (6 months), MMR vaccine (12 months), and Autism-specific screening (18 months).
Pediatric preventive care follows a highly structured timeline. The hepatitis B vaccine is administered at birth. At 2 months, infants receive their first set of primary series vaccines, including the live-attenuated rotavirus vaccine. By 6 months of age, infants become eligible for their first annual inactivated influenza vaccine. At 12 months of age, maternal antibodies have sufficiently waned to allow for the effective administration of live-attenuated vaccines such as the MMR (measles, mumps, and rubella) vaccine. Finally, while general developmental surveillance is ongoing, specialized universal screening for autism spectrum disorder (e.g., M-CHAT) is specifically recommended to begin at the 18-month well-child visit.

Step-by-Step Solution

1
Determine the timing for the first hepatitis B vaccine.
Birth (0 months).
It is the only vaccine routinely given in the newborn nursery before discharge.
2
Determine the timing for the first rotavirus vaccine.
2 months of age.
The primary series for rotavirus (along with DTaP, Hib, PCV, and IPV) begins at the 2-month well-child visit.
3
Determine the minimum age for the inactivated influenza vaccine.
6 months of age.
Infants become eligible for their first influenza vaccination at 6 months.
4
Determine the routine age for the first MMR vaccine.
12 months of age.
Live-attenuated vaccines like MMR and Varicella are given at 1 year of age, once maternal IgG has waned.
5
Determine the age for the first universal autism-specific screening.
18 months of age.
Standard pediatric guidelines recommend specific ASD screening (such as the M-CHAT) at 18 and 24 months.

Key Concept

Chronological scheduling of routine pediatric immunizations and developmental screening.
Question 366Question →

A term male neonate is evaluated in the delivery room immediately following an uncomplicated vaginal delivery at 40 weeks of gestation. His mother is a 28-year-old primigravida with negative prenatal screening for group B Streptococcus, syphilis, HIV, and hepatitis B. The infant's Apgar scores are 8 and 9 at 1 and 5 minutes, respectively. Physical examination reveals a vigorously crying infant with normal vital signs. Skin examination shows scattered, 2-mm vesiculopustules on the chin, neck, and trunk without any surrounding erythema. Several of the lesions have ruptured, revealing flat, hyperpigmented macules surrounded by a fine collarette of scale. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Continued observation and routine newborn care

Answer

The most appropriate management is continued observation and routine newborn care, as the findings are characteristic of a benign condition.
The patient's clinical presentation is classic for transient neonatal pustular melanosis (TNPM), a benign, self-limiting vesiculopustular eruption. Unlike erythema toxicum neonatorum, which typically appears on day 2 or 3 of life, TNPM is present at birth. It is characterized by small pustules on a non-erythematous base that easily rupture, leaving behind hyperpigmented macules with a characteristic 'collarette' of scale. Because the infant is well-appearing, vigorous, and has normal vital signs, infectious etiologies are highly unlikely. Therefore, the most appropriate management is continued observation, parental reassurance, and routine newborn care.

Step-by-Step Solution

1
Analyze the clinical presentation and timing of the rash.
The neonate presents immediately at birth with vesiculopustules lacking surrounding erythema, and ruptured lesions showing hyperpigmented macules with a fine scale.
Identifying the onset time (at birth) and specific morphological features differentiates benign physiological rashes from infectious etiologies.
2
Evaluate the infant's overall clinical status.
The neonate is vigorous, well-appearing, and has completely normal vital signs with reassuring Apgar scores.
Systemic stability effectively rules out severe infectious processes such as neonatal sepsis or disseminated viral infections.
3
Determine the appropriate management for the suspected diagnosis.
The diagnosis is transient neonatal pustular melanosis (TNPM), which requires no medical intervention.
Recognition of benign physiological skin changes in newborns dictates a conservative approach, avoiding unnecessary antibiotics or testing.

Key Concept

Transient neonatal pustular melanosis is a benign, self-resolving vesiculopustular rash present at birth that requires only routine observation.
Question 367Question →

A pediatric clinic is developing an educational brochure for parents regarding expected childhood development. The brochure will list major milestones in chronological order to help parents anticipate their child's progress. Arrange the following developmental milestones in the correct chronological sequence of their typical acquisition in a healthy child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The milestones should be ordered from earliest to latest: Social smile (2 months) -> Sits without support (6 months) -> Mature pincer grasp (12 months) -> Builds a tower of six cubes (24 months) -> Pedals a tricycle (36 months).
Childhood milestones develop in a highly predictable pattern across multiple domains. The social smile is an early social-emotional marker at 2 months. By 6 months, an infant achieves truncal tone sufficient for sitting without support. By 12 months, fine motor coordination refines to allow for a mature pincer grasp. At 24 months, advanced visual-motor skills permit the building of a tower of six blocks. Finally, by 36 months, complex gross motor coordination and balance enable the child to pedal a tricycle.

Step-by-Step Solution

1
Determine the typical age of acquisition for the social smile.
This milestone typically emerges at 2 months of age.
It is a key early social milestone marking responsive engagement with caregivers.
2
Determine the typical age of acquisition for sitting without support.
This milestone is typically achieved by 6 months of age.
Gross motor development progresses in a cephalocaudal direction; independent sitting follows head control and rolling over.
3
Determine the typical age of acquisition for a mature pincer grasp.
This milestone typically develops by 12 months of age.
Fine motor skill refines from a raking grasp (6 months) to an immature pad-to-pad pincer (9 months) and finally a mature fingertip-to-fingertip pincer (12 months).
4
Determine the typical age of acquisition for building a tower of six cubes.
This milestone is typically achieved by 24 months (2 years) of age.
Stacking blocks requires advanced hand-eye coordination that progresses significantly between 15 and 36 months.
5
Determine the typical age of acquisition for pedaling a tricycle.
This milestone is typically achieved by 36 months (3 years) of age.
Pedaling requires complex bilateral coordination and balance characteristic of a typical 3-year-old child.
6
Sequence the milestones in chronological order.
Social smile (2m) -> Sits unsupported (6m) -> Mature pincer grasp (12m) -> Tower of 6 cubes (24m) -> Pedals a tricycle (36m).
The question requests the order from earliest expected age to latest.

Key Concept

Normal pediatric developmental milestones occur in a predictable chronological sequence across gross motor, fine motor, language, and social-emotional domains, allowing clinicians to accurately assess developmental progress.
Question 368Question →

A female infant delivered at full term presents to the nursery staff on her second day of life with acute-onset lethargy and temperature instability. The mother is a healthy primiparous woman who had prolonged rupture of membranes lasting 2020 hours and an undocumented group B Streptococcus colonization status. Evaluation of the infant reveals a rectal temperature of 38.3∘C38.3^\circ\text{C} (100.9∘F100.9^\circ\text{F}), a heart rate of 165/min165/\text{min}, and a respiratory rate of 55/min55/\text{min} without accessory muscle use. The patient remains adequately perfused with a capillary refill time of 22 seconds and requires no respiratory support. Arrange the following actions in the definitive chronological order for the optimal diagnostic and therapeutic management of this infant.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for managing a stable neonate with suspected early-onset sepsis is: 1) Obtain blood and cerebrospinal fluid cultures, 2) Initiate empiric ampicillin and an aminoglycoside, 3) Monitor closely pending 36-48 hour culture results, and 4) Terminate antimicrobial therapy if cultures are negative and the infant has recovered.
The standard of care for a symptomatic neonate with suspected early-onset sepsis involves securing microbiologic samples (blood and CSF) prior to antibiotic administration, followed by the prompt initiation of empiric therapy. Once cultures prove sterile at 36 to 48 hours and the infant demonstrates clinical recovery, principles of antimicrobial stewardship dictate the immediate cessation of antibiotics.

Step-by-Step Solution

1
Obtain diagnostic microbiologic cultures (blood and cerebrospinal fluid).
Pathogen samples are secured prior to exposure to bactericidal agents.
Administering antibiotics before a lumbar puncture or blood draw can sterilize the fluids within hours, leading to false-negative results and preventing targeted narrowing of therapy.
2
Initiate empiric intravenous antimicrobial therapy.
The infant receives immediate coverage against leading early-onset sepsis pathogens.
Neonatal sepsis can rapidly progress to shock and death; therefore, once cultures are drawn, broad-spectrum antibiotics (ampicillin and gentamicin) must be started urgently.
3
Monitor clinically and await initial microbiologic data.
The patient's clinical trajectory is observed while laboratory incubations proceed.
It takes 36 to 48 hours for standard bacterial cultures to yield reliable preliminary results, during which time the infant requires supportive care.
4
Discontinue antimicrobial therapy.
Unnecessary antibiotic exposure is halted.
Principles of antimicrobial stewardship require stopping antibiotics in well-appearing infants with sterile 48-hour cultures to prevent adverse effects like necrotizing enterocolitis and the development of resistant organisms.

Key Concept

The sequential management of suspected early-onset neonatal sepsis prioritizes obtaining cultures prior to antibiotics in stable infants and strictly adhering to antimicrobial stewardship by stopping therapy at 48 hours if cultures are negative.
Question 369Question →

Match each pediatric patient presenting for a clinical visit with the most appropriate next step in their preventive care or immunization management.

Click a left item, then click its matching right item

Items

A 12-month-old boy with severe congenital T-cell lymphopenia (e.g., severe combined immunodeficiency) presenting for a well-child visit.
A 12-month-old girl whose mother received high-dose infliximab therapy throughout the third trimester of pregnancy, presenting for routine immunizations.
A 15-month-old girl presenting for routine immunizations whose household sibling recently underwent a bone marrow transplant and is severely immunocompromised.
A 4-month-old boy who was treated with intravenous immune globulin (IVIG) for Kawasaki disease 4 weeks ago, presenting for routine immunizations.
A 7-year-old boy with no prior immunizations presenting with a deep, dirty puncture wound from a rusted metal fence.

Matches

Show answer & explanation

Answer

The correct matches align specific high-risk pediatric scenarios with their respective modified immunization or post-exposure prophylaxis protocols based on altered immunocompetence, household exposures, and age constraints.
Each match correctly applies ACIP and Bright Futures guidelines for exceptional pediatric populations. The rules for live vaccines depend heavily on the mechanism of immunosuppression (cellular vs. passive antibody), the route of vaccine administration (parenteral vs. mucosal), and the exact timeline of exposure.

Step-by-Step Solution

1
Evaluate the 12-month-old with severe T-cell lymphopenia.
Match with withholding all live-attenuated vaccines.
Patients with severe cellular immunodeficiency cannot mount an adequate response to, and cannot safely clear, the attenuated viruses in live vaccines. Administration can cause fatal disseminated vaccine-strain infection.
2
Evaluate the 12-month-old with in utero infliximab exposure.
Match with administering MMR and varicella vaccines without delay.
IgG monoclonal antibodies cross the placenta. Infants are considered immunosuppressed for the first 6 months of life, contraindicating early live vaccines like rotavirus. At 12 months, the infant's immune system is normal, and MMR/varicella are safe.
3
Evaluate the 15-month-old sibling of a bone marrow transplant recipient.
Match with administering MMR/varicella but avoiding LAIV.
To protect immunocompromised family members, healthy contacts should be fully immunized, including with MMR and varicella. The only exception is LAIV (nasal flu spray), which is contraindicated because the attenuated virus can be shed and transmitted to the transplant recipient.
4
Evaluate the 4-month-old who received IVIG 4 weeks ago.
Match with administering the scheduled oral rotavirus vaccine.
IVIG provides passive serum IgG that interferes with injected live vaccines (MMR, varicella), necessitating a delay. It does not interfere with mucosal IgA responses in the gastrointestinal tract, so the live oral rotavirus vaccine is given on its strict age-based schedule.
5
Evaluate the completely unimmunized 7-year-old with a dirty wound.
Match with administering Tdap and TIG.
Unknown or <3 doses of tetanus toxoid plus a dirty wound requires both active (vaccine) and passive (TIG) prophylaxis. At age 7 years, the correct formulation is Tdap, as DTaP is contraindicated at age 7 and older.

Key Concept

Complex immunization management requires understanding the distinctions between cellular vs. humoral immunodeficiency, parenteral vs. mucosal live vaccines, and strict age cutoffs for specific vaccine formulations.
Question 370Question →

Macrosomic neonates are at increased risk for birth trauma, particularly during difficult or operative vaginal deliveries. Match each characteristic clinical presentation observed during the newborn physical examination with its most likely traumatic etiology.

Click a left item, then click its matching right item

Items

Adducted and internally rotated right arm with forearm pronation; absent Moro reflex but intact grasp on the affected side.
Claw-like posturing of the left hand with an absent grasp reflex, accompanied by ipsilateral ptosis and miosis.
Crepitus and palpable bony step-off over the anterior shoulder; decreased spontaneous arm movement but normal reflexes.
Respiratory distress with asymmetric chest wall expansion and paradoxical abdominal movement during inspiration.

Matches

Show answer & explanation

Answer

The presentations match as follows: 'waiter's tip' posture matches upper trunk injury (Erb palsy), claw hand with Horner syndrome matches lower trunk injury (Klumpke palsy), shoulder crepitus matches clavicular fracture, and asymmetric breathing matches phrenic nerve injury.
Each clinical presentation is a classic manifestation of a specific birth trauma. Accurate diagnosis requires localizing the neurological deficit (proximal vs. distal muscles) and identifying associated structural findings (crepitus, sympathetic deficit, or diaphragmatic paralysis).

Step-by-Step Solution

1
Analyze the pattern of motor deficits in the newborn's upper extremity.
Proximal weakness with an intact grasp indicates C5-C6 involvement; distal weakness with an absent grasp indicates C8-T1 involvement.
Different roots of the brachial plexus innervate specific muscle groups, allowing for precise clinical localization.
2
Assess for associated non-motor or extra-extremity physical signs.
Ipsilateral ptosis/miosis points to T1 sympathetic chain involvement; respiratory distress points to cervical roots C3-C5; crepitus points to a mechanical bone injury.
Recognizing associated findings helps differentiate isolated brachial plexus injuries from those involving adjacent structures or primary bone trauma.

Key Concept

Differentiating neonatal birth traumas based on characteristic physical examination findings and neurological localization.
Question 371Question →

Review the following physical examination findings of skin lesions in newborn infants. Associate each dermatologic presentation with its corresponding diagnosis.

Click a left item, then click its matching right item

Items

A 48-hour-old infant develops multiple erythematous macules on the trunk and extremities, some containing central yellow pustules; a smear of the pustules reveals numerous eosinophils.
A neonate is noted at birth to have scattered superficial pustules that easily rupture, leaving behind hyperpigmented macules with a collarette of scale; a smear reveals neutrophils.
A 24-hour-old infant presents with numerous tiny, 1-to-2 millimeter pearly white papules clustered over the nose, cheeks, and chin without surrounding erythema.
A 21-day-old infant develops inflammatory papules and pustules confined to the face and scalp, notably lacking comedones.

Matches

Show answer & explanation

Answer

The presentations match as follows: The infant with eosinophil-filled pustules has Erythema toxicum neonatorum. The newborn with neutrophil-filled pustules and hyperpigmented macules has Transient neonatal pustular melanosis. The infant with pearly white facial papules has Milia. The 21-day-old with facial papules lacking comedones has Neonatal cephalic pustulosis.
The correct pairings rely on identifying the classic distinguishing features of benign neonatal rashes. Erythema toxicum neonatorum typically appears a few days after birth and features eosinophil-filled pustules on an erythematous base. In contrast, Transient neonatal pustular melanosis is present at birth, lacks an erythematous base, contains neutrophils, and leaves hyperpigmented macules. Milia are simple keratin-filled cysts appearing as pearly white papules. Neonatal cephalic pustulosis presents later (around 3 weeks) with facial papules that specifically lack the comedones seen in true acne.

Step-by-Step Solution

1
Analyze the first presentation involving an erythematous rash with eosinophil-filled pustules appearing at 48 hours of life.
This pattern points to a common, benign newborn rash.
The presence of eosinophils and an erythematous base are the classic hallmarks of Erythema toxicum neonatorum.
2
Evaluate the second presentation involving neutrophil-filled pustules present at birth that leave hyperpigmented macules.
This indicates a specific transient eruption seen in neonates.
The lack of surrounding erythema, presence at birth, and neutrophil content define Transient neonatal pustular melanosis.
3
Assess the third presentation involving 1-to-2 millimeter pearly white papules on the face.
This indicates retention of keratin and sebaceous material.
These pinpoint white papules are characteristic of Milia.
4
Review the fourth presentation involving inflammatory facial papules at 3 weeks of age without comedones.
This indicates a condition similar to acne but lacking true comedones.
The timing and absence of comedones are the key distinguishing features of Neonatal cephalic pustulosis.

Key Concept

Differentiating benign neonatal skin eruptions based on timing of onset, physical appearance, and cellular contents of pustules.
Question 372Question →

A 9-month-old boy is brought to the clinic by his parents for a pre-travel consultation. The family will be traveling next week to a country experiencing an ongoing measles outbreak and plans to stay for two months. The patient was born at term, has no significant medical history, and is developing normally. He has received all routine childhood immunizations recommended for his age in the United States. His vital signs are within normal limits, and physical examination is unremarkable. Which of the following is the most appropriate recommendation regarding measles immunization for this patient?

Show answer & explanation

Answer: Administer one dose of the measles, mumps, and rubella (MMR) vaccine today, and administer the next routine dose at age 12 to 15 months.

Answer

The most appropriate action is to administer one dose of the MMR vaccine today, followed by the routine dose at 12 to 15 months.
The correct action is to administer the MMR vaccine today and continue with the routine series at 12 to 15 months. The standard childhood immunization schedule recommends the first dose of the live-attenuated measles, mumps, and rubella (MMR) vaccine at 12 to 15 months of age. Administration is delayed until this age because circulating transplacental maternal antibodies can interfere with the infant's ability to mount a robust and lasting immune response to the vaccine virus. However, infants between 6 and 11 months of age have waning maternal antibodies and are highly susceptible to measles infection. Therefore, for infants in this age group who are traveling internationally to areas with endemic measles or active outbreaks, the CDC recommends administering an early dose of the MMR vaccine to provide temporary protection. Because of the potential for blunted immunogenicity from residual maternal antibodies, this early dose is considered invalid for the routine series. The child must still receive the standard two doses (at 12-15 months and 4-6 years) to ensure lifelong immunity.

Step-by-Step Solution

1
Identify the patient's age and travel risk.
The patient is a 9-month-old infant traveling to a measles-endemic area.
Risk assessment determines whether standard immunization schedules need to be adjusted.
2
Determine the indication for measles vaccination in this age group.
Infants 6-11 months of age traveling internationally should receive an early dose of the MMR vaccine.
Maternal antibodies wane by this age, leaving the infant vulnerable in high-prevalence areas.
3
Evaluate how this early dose affects the routine schedule.
The early dose does not count toward the routine 2-dose series.
Maternal antibodies can blunt the immune response to the vaccine before 12 months of age, so the routine series must still be completed starting at 12-15 months.

Key Concept

Infants aged 6 to 11 months who are traveling internationally should receive one dose of the MMR vaccine prior to departure. This dose does not count toward the routine 2-dose series, which must still be administered starting at 12 to 15 months of age.
Question 373Question →

An 88-day-old newborn is evaluated in the pediatric clinic for a routine well-child visit. The mother is concerned about a skin eruption that appeared on the infant's face three days ago, which seemed to worsen after they sat in a sunlit room. The infant was born at 3939 weeks gestation via an uncomplicated vaginal delivery and is exclusively breastfeeding well. The mother is a 2828-year-old primigravida who has a history of episodic joint stiffness and cold-induced finger discoloration, for which she has not sought medical care. The infant's vital signs include a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 65/40 mmHg65/40 \text{ mmHg}, respiratory rate of 36/min36/\text{min}, and a heart rate of 72/min72/\text{min}. Physical examination of the infant reveals erythematous, annular plaques with slightly raised and scaly borders concentrated around the periorbital regions and scalp. The anterior fontanelle is flat and soft, and the lungs are clear to auscultation. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Perform an electrocardiogram

Answer

Perform an electrocardiogram
The correct answer is to perform an electrocardiogram. This infant presents with an erythematous, annular, and photosensitive rash predominantly affecting the periorbital regions (often described as 'raccoon eyes') and scalp. Combined with a maternal history suggestive of an undiagnosed connective tissue disease (joint stiffness, Raynaud phenomenon), this presentation is highly characteristic of neonatal lupus erythematosus (NLE). NLE is a passively transferred autoimmune disease caused by maternal anti-Ro/SSA and anti-La/SSB antibodies crossing the placenta. While the cutaneous findings are transient and resolve as maternal antibodies clear, the most serious complication is congenital heart block, which is often irreversible. This infant has profound resting bradycardia (heart rate 72/min72/\text{min}; normal is 110110-160/min160/\text{min}). An electrocardiogram is the essential next step to evaluate the cardiac rhythm and confirm the degree of atrioventricular block. Third-degree (complete) heart block may require immediate pacemaker placement.

Step-by-Step Solution

1
Evaluate the infant's vital signs against normal neonatal parameters.
The infant has profound bradycardia. A normal neonatal heart rate is 110110-160/min160/\text{min}, making a resting heart rate of 72/min72/\text{min} highly abnormal and concerning.
Identifying abnormal vital signs is the first crucial step in recognizing a potentially life-threatening condition.
2
Synthesize the infant's physical examination findings with the maternal history.
The infant's photosensitive, annular periorbital rash ('raccoon eyes'), combined with the mother's history of joint pain and Raynaud phenomenon, strongly suggests Neonatal Lupus Erythematosus (NLE).
NLE is an acquired autoimmune condition caused by the transplacental passage of maternal anti-Ro/SSA and anti-La/SSB antibodies.
3
Identify the most critical complication associated with the suspected diagnosis.
The most serious and potentially irreversible complication of NLE is congenital atrioventricular (AV) heart block, which accounts for the patient's severe bradycardia.
Congenital heart block has high morbidity and mortality, requiring immediate diagnostic confirmation.
4
Determine the most appropriate diagnostic test to assess the complication.
An electrocardiogram (ECG) must be performed immediately.
An ECG is required to determine the presence and degree of heart block, guiding the need for potential pacemaker placement.

Key Concept

Neonatal Lupus Erythematosus (NLE) and Congenital Heart Block
Question 374Question →

A pediatric clinic is auditing patient records to ensure adherence to specialized immunization guidelines for high-risk patients. Match each pediatric patient scenario with the most appropriate vaccine indication, absolute contraindication, or management step.

Click a left item, then click its matching right item

Items

A 4-year-old child with a newly placed cochlear implant who has received all routine childhood vaccinations
A 10-year-old child with sickle cell anemia presenting for a well-child visit, previously up-to-date on all condition-specific vaccinations
A 12-month-old infant with DiGeorge syndrome and a documented severe T-lymphocyte deficiency
A 7-year-old child who received high-dose intravenous immunoglobulin (IVIG) for Kawasaki disease exactly 3 months ago
A 15-year-old adolescent presenting for catch-up immunizations with a documented history of anaphylaxis to baker's yeast

Matches

Show answer & explanation

Answer

The correct pairings match each specialized clinical scenario to its corresponding vaccine management guideline based on structural defects (PPSV23 for cochlear implants), functional asplenia (MenB starting at age 10), severe cellular immunodeficiency (absolute MMR contraindication), passive immunity interference (11-month live vaccine deferral post-IVIG), and specific allergies (HepB/HPV contraindication for yeast allergy).
Each patient requires a specialized modification to the routine immunization schedule. Cochlear implants necessitate PPSV23 due to an increased risk of pneumococcal meningitis from potential CSF leaks. Functional asplenia requires MenB starting at age 10. Severe T-cell defects are absolute contraindications to live vaccines (MMR). High-dose IVIG for Kawasaki disease requires an 11-month temporary deferral of live vaccines (yielding 8 months remaining if 3 months have passed). Yeast anaphylaxis strictly contraindicates the HepB and HPV vaccines.

Step-by-Step Solution

1
Identify the underlying high-risk condition or status in each pediatric patient.
Recognize the presence of a cochlear implant, functional asplenia (sickle cell), severe T-cell deficiency, recent high-dose IVIG, and baker's yeast anaphylaxis.
Vaccine indications and contraindications depend heavily on these specific historical and clinical details rather than chronological age alone.
2
Determine appropriate pneumococcal and meningococcal vaccine indications for structural and functional defects.
The 4-year-old with a cochlear implant needs PPSV23. The 10-year-old with sickle cell anemia is newly eligible to start the MenB series.
Cochlear implants selectively increase pneumococcal meningitis risk (PPSV23 indicated >2 yrs). Asplenia increases broad encapsulated risk, and MenB is specifically approved and initiated at age 10.
3
Differentiate between temporary deferrals and absolute contraindications for live-attenuated vaccines.
The infant with severe T-cell deficiency has an absolute contraindication to MMR. The child who received IVIG 3 months ago requires an 11-month total deferral (8 additional months remaining).
Cellular immunodeficiency carries a fatal risk of vaccine-strain infection (absolute). Passive antibodies from IVIG merely blunt the immune response without causing harm (temporary).
4
Identify vaccine components related to specific severe allergies.
The adolescent with baker's yeast anaphylaxis cannot receive Hepatitis B or HPV vaccines.
Both of these vaccines are propagated in Saccharomyces cerevisiae and contain residual yeast proteins.

Key Concept

Vaccine modifications in special pediatric populations (immunocompromised, anatomic/functional defects, and specific allergies)
Estimated Time:2m 0s
Question 375Question →

A 39-week gestation male neonate is born via spontaneous vaginal delivery to a 28-year-old primigravida. The pregnancy was uncomplicated. At birth, the neonate is limp, apneic, and cyanotic. Place the following steps of neonatal resuscitation in the correct chronological order of execution according to standard neonatal resuscitation guidelines, assuming the neonate's clinical status does not improve and the heart rate remains consistently below 60/min despite each successive intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: initial steps (warmth, drying, stimulation) -> initiate PPV -> perform ventilation corrective steps -> commence chest compressions -> administer intravenous epinephrine.
The Neonatal Resuscitation Program (NRP) algorithm dictates a specific sequence to ensure that the primary cause of neonatal compromise—respiratory failure and hypoxia—is addressed first. The sequence begins with initial steps (warmth, drying, stimulation, clearing airway). If the infant remains apneic or the heart rate is < 100/min, PPV is initiated. If PPV fails to increase the heart rate and move the chest, ventilation corrective steps are performed. Only after establishing effective ventilation (chest movement) for 30 seconds, if the heart rate remains < 60/min, are chest compressions started alongside 100% oxygen. Finally, if the heart rate remains < 60/min after 60 seconds of coordinated compressions and effective PPV, intravenous epinephrine is administered.

Step-by-Step Solution

1
Identify the immediate requirements for a non-vigorous, apneic neonate at birth.
The first step is always to provide warmth, dry the infant, position the airway, and provide tactile stimulation.
Basic supportive care and stimulation can often restore spontaneous breathing and circulation without further invasive measures.
2
Determine the next step for persistent apnea or bradycardia (heart rate < 100/min) after initial steps.
Initiate positive-pressure ventilation (PPV) and attach monitoring equipment (pulse oximeter and ECG).
Neonatal bradycardia is typically secondary to hypoxia; establishing ventilation is the most critical intervention in neonatal resuscitation.
3
Determine the necessary action when PPV does not improve the heart rate and the chest is not moving.
Perform ventilation corrective steps (often memorized as MR. SOPA: Mask adjustment, Reposition airway, Suction mouth/nose, Open mouth, Pressure increase, Alternative airway).
Effective ventilation must be assured before escalating to compressions. Chest movement is the primary clinical indicator of effective PPV.
4
Identify the clinical threshold for initiating chest compressions.
Commence coordinated chest compressions and increase fractional inspired oxygen to 100%.
Compressions are indicated only if the heart rate remains < 60/min after at least 30 seconds of effective PPV that visibly moves the chest.
5
Determine when to administer resuscitation medications.
Administer intravenous epinephrine.
Epinephrine is indicated if the heart rate remains < 60/min despite 60 seconds of coordinated chest compressions and effective PPV.

Key Concept

Neonatal resuscitation follows a strict stepwise progression focused primarily on establishing effective ventilation, as hypoxia is the most common cause of neonatal bradycardia.
Question 376Question →

Evaluate the following neonatal clinical presentations characterized by gastrointestinal obstruction or feeding intolerance. Match each specific presentation to its precise underlying embryologic or pathophysiologic etiology.

Click a left item, then click its matching right item

Items

A 1-day-old neonate with marked hypotonia and upslanting palpebral fissures begins vomiting dark green material shortly after the first feeding. The abdomen is scaphoid. Upright radiography reveals two prominent upper abdominal air-fluid levels with a complete absence of distal intestinal gas.
A 2-day-old neonate whose mother had erratic prenatal care and a history of illicit stimulant use presents with bilious emesis and significant abdominal distension. Radiography reveals multiple dilated loops of bowel, several air-fluid levels, and a 'triple bubble' appearance.
A full-term male neonate fails to pass meconium by 48 hours of life. He develops severe feeding intolerance and a tensely distended abdomen. Contrast enema demonstrates a narrow-caliber rectum with a reversed rectosigmoid ratio and a distinct transition zone.
A 2-day-old neonate is evaluated for bilious emesis and failure to pass meconium. Radiography shows distended small bowel loops without discernible air-fluid levels and a frothy, granular density localized to the right lower quadrant.

Matches

Show answer & explanation

Answer

The presentations map to the following pathophysiologies: Vignette 1 is duodenal atresia (failure of recanalization). Vignette 2 is jejunoileal atresia (intrauterine vascular compromise). Vignette 3 is Hirschsprung disease (arrested neural crest cell migration). Vignette 4 is meconium ileus (ATP-binding cassette transporter mutation).
Each neonate presents with a distinct form of gastrointestinal obstruction. The 'double bubble' in a Down syndrome infant represents duodenal atresia (failure of recanalization). The 'triple bubble' with maternal cocaine use represents jejunal atresia (mesenteric vascular accident). The transition zone on contrast enema represents Hirschsprung disease (failure of neural crest migration). The ground-glass density without air-fluid interfaces represents meconium ileus due to Cystic Fibrosis (mutation in CFTR, an ATP-binding cassette transporter).

Step-by-Step Solution

1
Analyze the first clinical presentation and radiographic findings.
The dysmorphic features (Down syndrome) and 'double bubble' sign on X-ray identify duodenal atresia.
Identifying the specific congenital anomaly is prerequisite to determining its embryologic origin. Duodenal atresia uniquely arises from a failure of the bowel lumen to recanalize.
2
Evaluate the second presentation involving maternal stimulant use.
Maternal cocaine use and multiple air-fluid levels/triple bubble sign identify jejunoileal atresia.
Cocaine causes severe vasoconstriction. In the fetus, this leads to mesenteric vascular accidents, which cause ischemic necrosis and subsequent atresia of the jejunum or ileum.
3
Examine the third presentation involving contrast enema findings.
Delayed meconium passage with a transition zone and reversed rectosigmoid ratio diagnoses Hirschsprung disease.
The aganglionic segment remains tonically contracted, causing a functional obstruction. This is due to the failure of neural crest cells to migrate completely to the distal hindgut.
4
Assess the final presentation involving a 'granular density' on X-ray.
The ground-glass appearance (Neuhauser sign) without air-fluid levels indicates meconium ileus, a complication of Cystic Fibrosis.
Thickened meconium prevents the formation of clear air-fluid interfaces. Cystic Fibrosis is caused by defective chloride transport via the CFTR protein (an ATP-binding cassette transporter).

Key Concept

Embryologic and pathophysiologic mechanisms of neonatal gastrointestinal obstructions.
Estimated Time:2m 30s
Question 377Question →

During a routine evaluation in the newborn nursery, a physician examines a 48-hour-old female infant due to a newly developed skin eruption. The infant was born at 39 weeks of gestation via an uncomplicated vaginal delivery to a healthy mother who received standard prenatal care. Vital signs are within normal limits for age, and the infant is feeding vigorously at the breast. Physical examination reveals multiple erythematous macules, some containing central 1- to 2-millimeter yellowish pustules, scattered across the chest, abdomen, and bilateral thighs. The palms and soles are completely spared. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Routine neonatal care with no specific intervention

Answer

Routine neonatal care with no specific intervention
The correct approach is routine neonatal care with no specific intervention. This patient's presentation of scattered erythematous macules with central pustules, appearing at 48 hours of life and sparing the palms and soles, is the classic description of erythema toxicum neonatorum (ETN). ETN is a very common, benign, and self-limited idiopathic condition seen in full-term neonates. Because the infant is well-appearing, afebrile, and feeding normally, no diagnostic testing or pharmacologic treatment is indicated. The rash typically resolves spontaneously within a week.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
A healthy, afebrile 48-hour-old infant presents with an erythematous rash containing central pustules that spares the palms and soles.
Identifying the timing, morphology, and distribution of the rash is essential for distinguishing benign neonatal skin conditions from severe infectious etiologies.
2
Determine the most likely diagnosis.
The clinical picture is classic for erythema toxicum neonatorum (ETN).
ETN typically appears between 24 and 72 hours of life as erythematous macules with central papules or pustules, characteristically sparing the palms and soles.
3
Select the appropriate management strategy based on the diagnosis.
Reassurance and routine care are indicated.
ETN is a benign, asymptomatic, and self-resolving condition that requires no pharmacologic intervention or isolation.

Key Concept

Erythema toxicum neonatorum is a common, benign, self-limited rash in healthy newborns that presents as erythematous macules with central pustules (sparing palms and soles) and requires only parental reassurance and routine care.
Question 378Question →

A 32-year-old woman brings her 8-week-old daughter to the outpatient clinic for a scheduled preventive care encounter. The mother has a history of severe ulcerative colitis, which was managed with continuous intravenous infliximab therapy throughout her pregnancy; her most recent infusion occurred at 38 weeks gestation. The infant has been exclusively breastfed and demonstrates appropriate weight gain. Developmental assessment reveals that the infant coos, exhibits a social smile, and successfully tracks objects past the midline. Vital signs are within normal limits. Skin examination reveals a scattered eruption of small, firm, yellow-white papules surrounded by an erythematous halo over the trunk. The remainder of the physical examination is unremarkable. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer the first doses of DTaP, Hib, IPV, and PCV vaccines, and omit the rotavirus vaccine

Answer

Administer the first doses of DTaP, Hib, IPV, and PCV vaccines, and omit the rotavirus vaccine
The correct management is to administer the scheduled inactivated vaccines (DTaP, Hib, IPV, and PCV) but omit the live-attenuated rotavirus vaccine. Infliximab is a monoclonal IgG1 antibody that actively crosses the placenta, especially during the third trimester. Infants born to mothers receiving this therapy are considered immunocompromised for the first 6 months of life due to persistent circulating levels of the biologic drug. Consequently, live-attenuated vaccines (e.g., rotavirus, BCG) are contraindicated during this window due to the risk of uncontrolled vaccine-strain infection. Inactivated vaccines are safe and must not be delayed. The infant's rash is erythema toxicum neonatorum, a benign condition, and her milestones are entirely normal for her age.

Step-by-Step Solution

1
Assess the impact of maternal infliximab therapy on the infant's immune status.
Infliximab is an IgG1 monoclonal antibody that crosses the placenta, particularly during the third trimester, leaving the infant transiently immunocompromised for up to 6 months of age.
Understanding placental transfer of biologics is required to determine vaccine safety.
2
Determine the appropriate vaccine schedule for a 2-month-old infant with transient immunosuppression.
Inactivated vaccines (DTaP, Hib, IPV, PCV) are safe and should be given on schedule. The live-attenuated rotavirus vaccine is contraindicated and must be omitted.
Live-attenuated vaccines carry a risk of disseminated, potentially fatal infection in immunocompromised hosts.
3
Evaluate the infant's dermatologic findings and developmental milestones.
The yellow-white papules on an erythematous base indicate erythema toxicum neonatorum, which is benign. The milestones (cooing, social smile, tracking past midline) are normal for 8 weeks.
Rules out the need to delay vaccines for acute illness or refer for developmental delay.

Key Concept

Immunization management in infants exposed to transplacental biologic immunosuppressants
Question 379Question →

Correlate the following pediatric patient scenarios with the most appropriate targeted preventive care or immunization intervention.

Click a left item, then click its matching right item

Items

A 16-year-old adolescent with an inherited terminal complement pathway deficiency (C5-C9)
A healthy 1-year-old residing in a recently renovated urban apartment building constructed prior to 1960
A 2-year-old boy with homozygous sickle cell disease who has received all standard infant immunizations
A 24-month-old asymptomatic toddler who recently relocated from a region with widespread endemic tuberculosis

Matches

Show answer & explanation

Answer

Match the complement deficiency to the MenB vaccine, the older housing exposure to lead screening, the sickle cell disease to the PPSV23 vaccination, and the endemic region emigration to tuberculosis screening.
High-risk pediatric patients require precise modifications to standard preventive care. Asplenia (seen in sickle cell disease) necessitates PPSV23 to protect against encapsulated bacteria. Complement deficiencies require MenB to prevent severe meningococcal disease. Specific environmental and geographic exposures mandate targeted screening for lead toxicity and tuberculosis, respectively.

Step-by-Step Solution

1
Identify the primary underlying risk factor or exposure in each patient's clinical history.
Recognized complement deficiency, lead paint exposure risk, functional asplenia, and high-risk geographic origin.
Targeted preventive care relies on identifying specific risk factors that deviate from the standard, low-risk pediatric population.
2
Determine the indicated supplemental vaccine or screening test based on the identified risk.
Assigned MenB, lead testing, PPSV23, and TB screening to their respective clinical scenarios.
To correctly apply the guidelines from the Centers for Disease Control and Prevention and the American Academy of Pediatrics for high-risk patients.

Key Concept

Targeted preventive care and immunization schedules for high-risk pediatric populations.
Question 380Question →

A 38-week gestation male neonate is born via spontaneous vaginal delivery. Immediately after birth, he develops severe respiratory distress, cyanosis, and grunting. Physical examination reveals a scaphoid abdomen, absent breath sounds over the left hemithorax, and heart sounds displaced to the right. The medical team highly suspects a congenital diaphragmatic hernia. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is endotracheal intubation, followed by orogastric tube placement, then chest radiography, and finally surgical repair.
The standard sequence for managing a newborn with a suspected congenital diaphragmatic hernia focuses on immediate airway control without introducing air into the GI tract (endotracheal intubation), followed by GI decompression (orogastric tube), diagnostic confirmation (radiograph), and delayed definitive treatment (surgery) once pulmonary status is stable.

Step-by-Step Solution

1
Secure the airway
Endotracheal intubation is performed
Bag-mask ventilation must be avoided to prevent gastrointestinal distension and worsening respiratory compromise.
2
Decompress the gastrointestinal tract
Orogastric tube is placed
Decompressing the herniated bowel relieves pressure on the already hypoplastic lungs, improving ventilation.
3
Confirm the diagnosis
Chest radiography is obtained
A chest X-ray confirms the presence of bowel loops in the thorax after the patient is hemodynamically and chronotropically stabilized.
4
Perform definitive treatment
Surgical repair is scheduled
Surgery is the definitive treatment but must be delayed until pulmonary hypertension and cardiopulmonary status are optimized.

Key Concept

Initial management sequence for Congenital Diaphragmatic Hernia (CDH)
PreviousPage 19 / 55Next
Pediatrics Practice Questions — USMLE Step 2 CK — Page 19 | Examkin